TG8-260
TG8-260 is a potent and orally bioavailable EP2 receptor antagonist developed for research on neuroinflammatory and peripheral inflammatory diseases. It demonstrates efficacy in reducing gliosis and inflammation in rodent seizure models and inhibits pro-inflammatory gene expression in microglial cell assays, supporting its use in both in vivo and in vitro anti-inflammatory pathway studies.
Product Specifications
CAS Number
2490544-50-6
Field of Research
Immunology & Inflammation, Pharmacology & Drug Discovery
Purity
98.02% (May vary between batches)
Smiles
O=C (NCCC=1C=2C=CC=CC2NC1C) C=3C=CC (=CC3) C4=CN=CN4
Molecular Formula
C21H20N4O
Molecular Weight
344.41
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
VAng-Lsx06461-1mgEcoli 1 mg (E. coli)
Recombinant Mycoplasma Hyopneumoniae mhp112 Protein (aa 1-317)
Sign In for Pricing
View Details 
MBS553810-01 0.05 mg
Biotinylated Human ACE2/ACEH Protein Recombinant
Sign In for Pricing
View Details MBS553810-02 0.25 mg
Biotinylated Human ACE2/ACEH Protein Recombinant
Sign In for Pricing
View Details